UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 389

Sortiert nach

Prognostic significance of pre-transplant quality of life in allogeneic hematopoietic cell transplantation recipients

Bone marrow transplantation (Basingstoke), 2015-09, Vol.50 (9), p.1235-1240

2015

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for vancomycin-resistant enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation

Bone marrow transplantation (Basingstoke), 2014-10, Vol.49 (10), p.1310-1316

2014

Link zum Volltext

Verfügbarkeit prüfen

A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation

Bone marrow transplantation (Basingstoke), 2004-10, Vol.34 (7), p.621-625

2004

Link zum Volltext

Verfügbarkeit prüfen

Impact of cigarette smoking on survival after myeloablative allogeneic hematopoietic stem cell transplantation and contribution of invasive fungal infection

Bone marrow transplantation (Basingstoke), 2017-12, Vol.52 (12), p.1665-1667

2017

Link zum Volltext

Verfügbarkeit prüfen

Association of socioeconomic status with long-term outcomes in 1-year survivors of allogeneic hematopoietic cell transplantation

Bone marrow transplantation (Basingstoke), 2015-10, Vol.50 (10), p.1326-1330

2015

Link zum Volltext

Verfügbarkeit prüfen

Association of socioeconomic status with autologous hematopoietic cell transplantation outcomes for lymphoma

Bone marrow transplantation (Basingstoke), 2016-09, Vol.51 (9), p.1191-1196

2016

Link zum Volltext

Verfügbarkeit prüfen

STARE DECISIS AND THE SUPREME COURT(S): WHAT STATES CAN LEARN FROM GAMBLE

The Notre Dame law review, 2020-03, Vol.95 (4), p.1731

Pohlman, Zachary B

2020

Link zum Volltext

Verfügbarkeit prüfen

GvHD-free, relapse-free survival after reduced-intensity allogeneic hematopoietic cell transplantation in older patients with myeloid malignancies

Bone marrow transplantation (Basingstoke), 2016-12, Vol.51 (12), p.1642-1643

2016

Link zum Volltext

Verfügbarkeit prüfen

Fludarabine as a risk factor for poor stem cell harvest, treatment-related MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation

Bone marrow transplantation (Basingstoke), 2012-04, Vol.47 (4), p.488-493

2012

Link zum Volltext

Verfügbarkeit prüfen

Intravenous compared with oral busulfan as preparation for allogeneic hematopoietic progenitor cell transplantation for AML and MDS

Bone marrow transplantation (Basingstoke), 2012-05, Vol.47 (5), p.633-638

2012

Link zum Volltext

Verfügbarkeit prüfen

SAFETY AND EFFICACY OF VENETOCLAX COMBINED WITH RITUXIMAB, IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE (VICER) FOR TREATMENT OF RELAPSED DLBCL: FINAL RESULTS FROM THE PHASE 1TRIAL

Hematological oncology, 2019-06, Vol.37 (S2), p.329-330

2019

Link zum Volltext

Verfügbarkeit prüfen

What Is Caesar's, What Is God's: Fundamental Public Policy For Churches

Harvard journal of law and public policy, 2021-01, Vol.44 (1), p.145-238

2021

Link zum Volltext

Verfügbarkeit prüfen

Etoposide plus G-CSF priming compared with G-CSF alone in patients with lymphoma improves mobilization without an increased risk of secondary myelodysplasia and leukemia

Bone marrow transplantation (Basingstoke), 2012-02, Vol.47 (2), p.231-235

2012

Link zum Volltext

Verfügbarkeit prüfen

Insulin Administration And The Impacts Of Forgetting A Dose For Patients

Value in health, 2013-05, Vol.16 (3), p.A170-A170

2013

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of autologous hematopoietic cell transplantation in primary amyloidosis after bortezomib-based induction therapy

Bone marrow transplantation (Basingstoke), 2016-05, Vol.51 (5), p.732-734

2016

Link zum Volltext

Verfügbarkeit prüfen

Elevated pretransplant serum ferritin is associated with inferior survival following nonmyeloablative allogeneic transplantation

Bone marrow transplantation (Basingstoke), 2009-12, Vol.44 (11), p.767-768

2009

Link zum Volltext

Verfügbarkeit prüfen

Patients mobilizing large numbers of CD34+ cells ('super mobilizers') have improved survival in autologous stem cell transplantation for lymphoid malignancies

Bone marrow transplantation (Basingstoke), 2007-09, Vol.40 (5), p.437-441

2007

Link zum Volltext

Verfügbarkeit prüfen

BU- vs TBI-based conditioning for adult patients with ALL

Bone marrow transplantation (Basingstoke), 2011-11, Vol.46 (11), p.1413-1417

2011

Link zum Volltext

Verfügbarkeit prüfen

Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection

Bone marrow transplantation (Basingstoke), 2004-12, Vol.34 (12), p.1071-1075

2004

Link zum Volltext

Verfügbarkeit prüfen

Long-term follow-up of a prospective randomized trial comparing CYA and MTX with CYA and mycophenolate mofetil for GVHD prophylaxis in myeloablative sibling donor hematopoietic cell transplantation

Bone marrow transplantation (Basingstoke), 2013-11, Vol.48 (12), p.1578-1580

2013

Link zum Volltext

Verfügbarkeit prüfen

PDB69 the Impact of Nocturnal Hypoglycemic Events on Functioning, Well-Being and Diabetes Management

Value in health, 2012-06, Vol.15 (4), p.A183-A183

2012

Link zum Volltext

Verfügbarkeit prüfen

Severe mucositis is associated with reduced survival after autologous stem cell transplantation for lymphoid malignancies

British journal of haematology, 2006-11, Vol.135 (3), p.374-381

2006

Link zum Volltext

Verfügbarkeit prüfen

Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCT

Bone marrow transplantation (Basingstoke), 2011-01, Vol.46 (1), p.84-89

2011

Link zum Volltext

Verfügbarkeit prüfen

Prognostic importance of the platelet count 100 days post allogeneic bone marrow transplant

Bone marrow transplantation (Basingstoke), 2004-02, Vol.33 (4), p.419-423

2004

Link zum Volltext

Verfügbarkeit prüfen

Apheresis days required for harvesting CD34+ cells predicts hematopoietic recovery and survival following autologous transplantation

Bone marrow transplantation (Basingstoke), 2011-12, Vol.46 (12), p.1519-1525

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 389

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(319)
Mit Volltextzugriff
(358)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(227)
Life Sciences & Biomedicine
(197)
Humans
(154)
Biological And Medical Sciences
(128)
Female
(124)
Male
(124)
Middle Aged
(117)
Adult
(102)
Medical Sciences
(98)
Aged
(76)
Oncology
(66)
Hematology
(61)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(59)
Transplantation
(55)
Immunology
(54)
Stem Cell Transplantation
(53)
Biophysics
(51)
General & Internal Medicine
(48)
Bone Marrow
(46)
Transfusions. Complications. Transfusion Reactions. Cell And Gene Therapy
(42)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prognostic significance of pre-transplant quality of life in allogeneic hematopoietic cell transplantation recipients

Risk factors for vancomycin-resistant enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation

A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation

Impact of cigarette smoking on survival after myeloablative allogeneic hematopoietic stem cell transplantation and contribution of invasive fungal infection

Association of socioeconomic status with long-term outcomes in 1-year survivors of allogeneic hematopoietic cell transplantation

Association of socioeconomic status with autologous hematopoietic cell transplantation outcomes for lymphoma

STARE DECISIS AND THE SUPREME COURT(S): WHAT STATES CAN LEARN FROM GAMBLE

GvHD-free, relapse-free survival after reduced-intensity allogeneic hematopoietic cell transplantation in older patients with myeloid malignancies

Fludarabine as a risk factor for poor stem cell harvest, treatment-related MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation

Intravenous compared with oral busulfan as preparation for allogeneic hematopoietic progenitor cell transplantation for AML and MDS

SAFETY AND EFFICACY OF VENETOCLAX COMBINED WITH RITUXIMAB, IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE (VICER) FOR TREATMENT OF RELAPSED DLBCL: FINAL RESULTS FROM THE PHASE 1TRIAL

What Is Caesar's, What Is God's: Fundamental Public Policy For Churches

Etoposide plus G-CSF priming compared with G-CSF alone in patients with lymphoma improves mobilization without an increased risk of secondary myelodysplasia and leukemia

Insulin Administration And The Impacts Of Forgetting A Dose For Patients

Outcomes of autologous hematopoietic cell transplantation in primary amyloidosis after bortezomib-based induction therapy

Elevated pretransplant serum ferritin is associated with inferior survival following nonmyeloablative allogeneic transplantation

Patients mobilizing large numbers of CD34+ cells ('super mobilizers') have improved survival in autologous stem cell transplantation for lymphoid malignancies

BU- vs TBI-based conditioning for adult patients with ALL

Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection

Long-term follow-up of a prospective randomized trial comparing CYA and MTX with CYA and mycophenolate mofetil for GVHD prophylaxis in myeloablative sibling donor hematopoietic cell transplantation

PDB69 the Impact of Nocturnal Hypoglycemic Events on Functioning, Well-Being and Diabetes Management

Severe mucositis is associated with reduced survival after autologous stem cell transplantation for lymphoid malignancies

Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCT

Prognostic importance of the platelet count 100 days post allogeneic bone marrow transplant

Apheresis days required for harvesting CD34+ cells predicts hematopoietic recovery and survival following autologous transplantation

Suchergebnisse filtern